Update: Eli Lilly Says its Zepbound Showed 47% 'Greater Relative Weight Loss' Against Wegovy in Phase 3b Trial

Stoke Therapeutics' Zorevunersen Gets FDA Breakthrough Therapy Status in Dravet Syndrome

Cross Country Healthcare to be Acquired by Aya Healthcare and Taken Private for $18.61 per Share in Cash

Update: Market Chatter: TPG Exploring Sale of Crunch Fitness for Over $1.5 Billion

Relmada Therapeutics' Late-Stage Trial of REL-1017 Deemed 'Futile' -- Shares Decline Pre-Bell

Theratechnologies to Commercialize Two RNA-targeted Medicines in Canada

Snoop Dogg helps Publicis claim world's largest ad group title

Update: Market Chatter: Ellison Plans to Consolidate Paramount Cable, Broadcast Units, Trim CEO Trio

Scotiabank Previews Wednesday's Canada Labor Productivity for Q3